Jacob Moller
3 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| The Metabolic Effects of Empagliflozin in Patients With High Risk of Heart Failure (NCT05042973) | Jacob Moller | 2021-09-02 |
| The Cardiac Effects of Empagliflozin in Patients With High Risk of Heart Failure (NCT05084235) | Jacob Moller | 2021-09-02 |
| Angiotensin-Neprilysin Inhibition in Diastolic Dysfunction After AMI (NCT04149990) | Jacob Moller | 2018-10-12 |
Track Jacob Moller automatically
Every clearance here is in the API, with alerts when new ones post.